← Back to the fund pageUse your browser's print dialog and choose “Save as PDF”. A4, two pages.
InvestVerdict
Tata Nifty MidSmall Healthcare Index Fund
Regular Plan · IDCW Payout Option · Index Funds · Scheme code 152562
NAV₹15.2534as on 28 Aug 2026
Fund houseTata Mutual Fund
CategoryIndex Funds
Plan & optionRegular · IDCW Payout Option
History2.3 years
Returns (%)
1M
3M
6M
1Y
3Y
5Y
7Y
10Y
Launch
This scheme
1.05
10.19
19.51
20.21
—
—
—
—
19.48
Nifty 100 benchmark
0.25
3.49
-1.52
1.84
10.52
9.38
—
—
12.79
Index Funds category median
—
—
—
5.59
7.63
8.89
—
11.16
—
Over a year annualised (CAGR), under a year absolute. Computed from AMFI's published
NAV history for this scheme.
Risk
Volatility
Sharpe
Sortino
Beta
Alpha
Max fall
R²
This scheme
15.8%
0.82
1.17
0.73
15.26%
-17.6%
39.67
Nifty 100 benchmark
17.1%
0.23
0.32
—
—
-37.0%
—
Risk-free rate 6.5%. Beta, alpha and R² are regressed on the
28 months this scheme and its benchmark share.
Growth of ₹100 since launch
Drawdown from peak (%)
Every one-year period it has lived through
Windows
Worst
Median
Best
Periods that lost money
66
-2.1%
11.3%
25.0%
6%
Every one-year holding period in this scheme's history, not just the last one — the
spread a real investor would have met depending only on when they started.
InvestVerdict
Tata Nifty MidSmall Healthcare Index Fund
Regular Plan · IDCW Payout Option
Allocation
By asset
Equity
100.06%
By market cap
Mid Cap
68.31%
Small Cap
31.75%
Concentration
Number of stocks
30
Top 5 stocks
38.81%
Top 10 stocks
60.20%
Top 20 stocks
85.82%
Largest holding
9.36%
Largest sector
Pharmaceuticals & Biotechnology 77.53%
Effective stocks
20.2
Cash
-0.13%
InvestVerdict
Tata Nifty MidSmall Healthcare Index Fund
Regular Plan · IDCW Payout Option · holdings
Top 18 holdings
#
Company
Sector
% of fund
1
—
Pharmaceuticals & Biotechnology
9.36%
2
—
Pharmaceuticals & Biotechnology
9.30%
3
—
Healthcare Services
7.90%
4
—
Pharmaceuticals & Biotechnology
6.99%
5
—
Pharmaceuticals & Biotechnology
5.26%
6
—
Pharmaceuticals & Biotechnology
5.17%
7
—
Pharmaceuticals & Biotechnology
4.73%
8
—
Pharmaceuticals & Biotechnology
4.56%
9
—
Pharmaceuticals & Biotechnology
3.74%
10
—
Healthcare Services
3.19%
11
—
Healthcare Services
3.15%
12
—
Pharmaceuticals & Biotechnology
3.15%
13
—
Pharmaceuticals & Biotechnology
2.98%
14
—
Pharmaceuticals & Biotechnology
2.69%
15
—
Pharmaceuticals & Biotechnology
2.54%
16
—
Pharmaceuticals & Biotechnology
2.54%
17
—
Pharmaceuticals & Biotechnology
2.28%
18
—
Healthcare Services
2.16%
Sector split
Pharmaceuticals & Biotechnology
77.53%
Healthcare Services
21.51%
Healthcare Equipment & Supplies
1.02%
Not investment advice. InvestVerdict is not a SEBI-registered Investment
Adviser or Research Analyst. Every figure is computed from AMFI's published NAV history and the
portfolio the AMC filed with AMFI; none of it is a recommendation to buy, hold or sell. Past
returns do not predict future ones. Generated 30 Aug 2026.